DK207575A - Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri - Google Patents

Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri

Info

Publication number
DK207575A
DK207575A DK207575A DK207575A DK207575A DK 207575 A DK207575 A DK 207575A DK 207575 A DK207575 A DK 207575A DK 207575 A DK207575 A DK 207575A DK 207575 A DK207575 A DK 207575A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
active compounds
medicinal product
psychotropic effect
Prior art date
Application number
DK207575A
Other languages
Danish (da)
English (en)
Inventor
W Konig
R Geiger
H Wissmann
H J Kruse
Peterfalvi
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK207575A publication Critical patent/DK207575A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK207575A 1974-05-14 1975-05-12 Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri DK207575A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2423389A DE2423389A1 (de) 1974-05-14 1974-05-14 Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DK207575A true DK207575A (da) 1975-11-15

Family

ID=5915522

Family Applications (1)

Application Number Title Priority Date Filing Date
DK207575A DK207575A (da) 1974-05-14 1975-05-12 Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri

Country Status (11)

Country Link
US (1) US4053588A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS50157361A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE829058A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1067410A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2423389A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK207575A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2270867B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1503680A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE41055B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU72449A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7505479A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
JPH0822819B2 (ja) * 1986-02-28 1996-03-06 ハフスルンド ナイコメド アクチスカベット 細胞生長調節作用を有するジペプチドを含有する薬学的製剤
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
AU2004266641A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
SG149828A1 (en) 2003-10-03 2009-02-27 3M Innovative Properties Co Alkoxy substituted imidazoquinolines
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
KR101130928B1 (ko) 2003-11-25 2012-04-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 치환된 이미다조 고리 시스템 및 방법
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
TW200612932A (en) 2004-03-24 2006-05-01 3M Innovative Properties Co Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
CA2594674C (en) 2004-12-30 2016-05-17 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006074003A2 (en) 2004-12-30 2006-07-13 3M Innovative Properties Company CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
WO2006074045A2 (en) * 2004-12-30 2006-07-13 3M Innovative Properties Company Immune response modifier formulations and methods
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
US7968563B2 (en) 2005-02-11 2011-06-28 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ,インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
DE102014110783A1 (de) * 2014-07-30 2016-02-04 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE63496C (de) * B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes
US3002978A (en) * 1958-05-06 1961-10-03 Bocher Gustave Marie Joseph Glyceryl pyrrolidone carboxylates
FR2207707A1 (en) * 1972-11-27 1974-06-21 Fabre Sa Pierre 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity

Also Published As

Publication number Publication date
LU72449A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-02-09
GB1503680A (en) 1978-03-15
NL7505479A (nl) 1975-11-18
IE41055B1 (en) 1979-10-10
FR2270867B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-08-04
JPS50157361A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-12-19
DE2423389A1 (de) 1975-12-04
CA1067410A (en) 1979-12-04
IE41055L (en) 1975-11-14
BE829058A (fr) 1975-11-14
FR2270867A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-12-12
US4053588A (en) 1977-10-11

Similar Documents

Publication Publication Date Title
DK207575A (da) Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri
DK524275A (da) Stobt og sammenklemmelig oplosningsbeholder samt form til fremstilling af samme
SE427323B (sv) Engangsbloja
DK119276A (da) Non-thrombogen medicinsk genstand samt fremgangsmade til fremstilling deraf
DK371277A (da) Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning
NL7413085A (nl) Farmaceutisch en/of cosmetisch preparaat uitwendig gebruik.
DK38077A (da) Fremgangsmade til fremstilling af dinatriumcromoglycat og farmaceutiske kompositioner indeholdende dette
DK269175A (da) Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin
DK132519C (da) Fremgangsmade til fremstilling af et stabilt medicinsk preparat indeholdende indomethacin samt beremedium til anvendelse ved fremgangsmaden
DK150193C (da) Fremgangsmaade til fremstilling af et amorft lactulosepulver til terapeutisk anvendelse
DK222975A (da) Fremgangsmade til fremstilling af polysocyanater og disses anvendelse
DK132372C (da) Fremgangsmade til fremstilling af tamponer og anleg til udovelse af fremgangsmaden
FI65910B (fi) Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
DK248975A (da) Fremgangsmade og farmaceutisk preparat til behandling af hypercholesterolemia
DK548275A (da) Peptider med blodtrykssenkende virkning og fremgangsmade til deres fremstilling
IT1043490B (it) Procedimento e dispositivo per la fabbricazione di pnfumatici
DK201275A (da) Oplosninger af komplekse antimonforbindelser samt fremgangsmade til disses fremstilling og anvendelse
DK144752C (da) Dentalpulver og anvendelse deraf til fremstilling af tandfyldninger
DK135997C (da) 17alfa-hydroxy-1,3,5(10),15-ostratetraener til anvendelse sommellemprodukter for fremstilling af 15alfa,16alfa-methylen-4-ostren-17beta-oler og fremgangsmade til fremstilling af mellemprodukterne
DK256975A (da) Fremgangsmade til fremstilling af cephalosporiner og mellemliggende produkter
DK287176A (da) Farmaceutisk kombinationspreparat og dets anvendelse
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK137376A (da) Fremgangsmade til fremstilling af farmaceutisk produkt indeholdende triamteren og cyclothiazid
DK326475A (da) Fremgangsmade til fremstilling af nbetasubstituerede 8-beta-aminoethylergolin-iderivater og salte deraf
DK354480A (da) Fremgangsmaade til fremstilling af veterinaermedicinsk depotpraeparat med forlaenget virkning

Legal Events

Date Code Title Description
ATS Application withdrawn